Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Microbiology and Immunology
Published in: Medical Microbiology and Immunology 1/2006

01-03-2006 | Original Investigation

Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus

Authors: Georg Häcker, Susanne Kirschnek, Silke F. Fischer

Published in: Medical Microbiology and Immunology | Issue 1/2006

Login to get access

Abstract

Cell death by apoptosis is a common response of a human cell to many extrinsic stimuli. A cell’s sensitivity to apoptotic triggers is affected by its activation and differentiation status. Bacteria are recognised by cellular receptors and elicit a multitude of signal transduction events that can, among other effects, alter the cell’s response towards apoptotic stimuli. Many different bacteria and bacterial products have been recognised as agents that can act in this way and either induce or inhibit cell death. Besides these common and, as we argue, indirect activities, chlamydiae have been described to have a more specific capacity. These specialists of intracellular life can directly attack the host cell’s apoptotic pathway. Here, we will attempt to structure the field of bacterial inhibition of apoptosis and discuss recent advancements in our knowledge of how chlamydiae interfere with the host cell’s capacity to undergo apoptosis.
Literature
1.
Ashkenazi A, Dixit VM (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255–260CrossRefPubMed
2.
3.
Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626–629PubMed
4.
Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897–907CrossRefPubMed
5.
Boatright KM, Deis C, Denault JB, Sutherlin DP, Salvesen GS (2004) Activation of caspases-8 and—10 by FLIP(L). Biochem J 382:651–657CrossRefPubMed
6.
Adams JM, Cory S (2001) Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61–66CrossRefPubMed
7.
Bouillet P, Strasser A (2002) BH3-only proteins—evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 115:1567–1574PubMed
8.
Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735–1738CrossRefPubMed
9.
Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, Kappler J, Marrack P (2002) Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16:759–767CrossRefPubMed
10.
Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A (2000) The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J 19:3325–3336CrossRefPubMed
11.
Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, Hacker G, Holzmann B, Heesemann J (2004) Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J Immunol 173:3320–3328PubMed
12.
Fischer SF, Rehm M, Bauer A, Hofling F, Kirschnek S, Rutz M, Bauer S, Wagner H, Hacker G (2005) Toll-like receptor 9 signaling can sensitize fibroblasts for apoptosis. Immunol Lett 97:115–122CrossRefPubMed
13.
Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743–748PubMed
14.
Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511PubMed
15.
Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167–170CrossRefPubMed
16.
Makris C, Godfrey VL, Krahn-Senftleben G, Takahashi T, Roberts JL, Schwarz T, Feng L, Johnson RS, Karin M (2000) Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 5:969–979CrossRefPubMed
17.
Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM (1999) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321–325CrossRefPubMed
18.
Kreuz S, Siegmund D, Scheurich P, Wajant H (2001) NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21:3964–3973CrossRefPubMed
19.
Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J (2001) NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299–5305CrossRefPubMed
20.
21.
Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280–288CrossRefPubMed
22.
Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012–2020PubMed
23.
Yamamoto C, Yoshida S, Taniguchi H, Qin MH, Miyamoto H, Mizuguchi Y (1993) Lipopolysaccharide and granulocyte colony-stimulating factor delay neutrophil apoptosis and ingestion by guinea pig macrophages. Infect Immun 61:1972–1979PubMed
24.
Yoshiie K, Kim HY, Mott J, Rikihisa Y (2000) Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun 68:1125–1133CrossRefPubMed
25.
Kim JS, Kim JM, Jung HC, Song IS, Kim CY (2001) Inhibition of apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins. Scand J Gastroenterol 36:589–600CrossRefPubMed
26.
Ozaki K, Hanazawa S (2001) Porphyromonas gingivalis fimbriae inhibit caspase-3-mediated apoptosis of monocytic THP-1 cells under growth factor deprivation via extracellular signal-regulated kinase-dependent expression of p21 Cip/WAF1. Infect Immun 69:4944–4950CrossRefPubMed
27.
Feterowski C, Weighardt H, Emmanuilidis K, Hartung T, Holzmann B (2001) Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis. Eur J Immunol 31:1268–1277CrossRefPubMed
28.
Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A (1999) Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736–739CrossRefPubMed
29.
Ruckdeschel K, Harb S, Roggenkamp A, Hornef M, Zumbihl R, Kohler S, Heesemann J, Rouot B (1998) Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J Exp Med 187:1069–1079CrossRefPubMed
30.
Binnicker MJ, Williams RD, Apicella MA (2004) Gonococcal porin IB activates NF-kappaB in human urethral epithelium and increases the expression of host antiapoptotic factors. Infect Immun 72:6408–6417CrossRefPubMed
31.
Clifton DR, Goss RA, Sahni SK, van Antwerp D, Baggs RB, Marder VJ, Silverman DJ, Sporn LA (1998) NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection. Proc Natl Acad Sci USA 95:4646–4651CrossRefPubMed
32.
Joshi SG, Francis CW, Silverman DJ, Sahni SK (2003) Nuclear factor kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity. Infect Immun 71:4127–4136CrossRefPubMed
33.
Joshi SG, Francis CW, Silverman DJ, Sahni SK (2004) NF-kappaB activation suppresses host cell apoptosis during Rickettsia rickettsii infection via regulatory effects on intracellular localization or levels of apoptogenic and anti-apoptotic proteins. FEMS Microbiol Lett 234:333–341CrossRefPubMed
34.
Kempf VA, Schairer A, Neumann D, Grassl GA, Lauber K, Lebiedziejewski M, Schaller M, Kyme P, Wesselborg S, Autenrieth IB (2005) Bartonella henselae inhibits apoptosis in Mono Mac 6 cells. Cell Microbiol 7:91–104CrossRefPubMed
35.
Schmid MC, Schulein R, Dehio M, Denecker G, Carena I, Dehio C (2004) The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells. Mol Microbiol 52:81–92CrossRefPubMed
36.
Wahl C, Oswald F, Simnacher U, Weiss S, Marre R, Essig A (2001) Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun 69:7039–7045CrossRefPubMed
37.
Fischer SF, Schwarz C, Vier J, Hacker G (2001) Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells. Infect Immun 69:7121–7129CrossRefPubMed
38.
Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13:2905–2927CrossRefPubMed
39.
Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG (2000) Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 1:533–540CrossRefPubMed
40.
Strassheim D, Asehnoune K, Park JS, Kim JY, He Q, Richter D, Kuhn K, Mitra S, Abraham E (2004) Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol 172:5727–5733PubMed
41.
Yilmaz O, Jungas T, Verbeke P, Ojcius DM (2004) Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis. Infect Immun 72:3743–3751CrossRefPubMed
42.
Knodler LA, Finlay BB, Steele-Mortimer O (2005) The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J Biol Chem 280(10):9058–9064CrossRefPubMed
43.
Teodoro JG, Branton PE (1997) Regulation of apoptosis by viral gene products. J Virol 71:1739–1746PubMed
44.
Xu XN, Screaton GR, McMichael AJ (2001) Virus infections: escape, resistance, and counterattack. Immunity 15:867–870CrossRefPubMed
45.
Prebeck S, Kirschning C, Durr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T (2001) Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167:3316–3323PubMed
46.
Byrne GI, Ojcius DM (2004) Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2:802–808CrossRefPubMed
47.
Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR (2004) Prevalence of chlamydial and gonococcal infections among young adults in the United States. Jama 291:2229–2236CrossRefPubMed
48.
Thylefors B, Negre AD, Pararajasegaram R, Dadzie KY (2005) Global data on blindness. Bull World Health Organ 73:115
49.
Kuo CC, Jackson LA, Campbell LA, Grayston JT (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451–461PubMed
50.
Greene W, Xiao Y, Huang Y, McClarty G, Zhong G (2004) Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun 72:451–460CrossRefPubMed
51.
Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM, Greenberg AH, Zhong G (1998) Inhibition of Apoptosis in Chlamydia-infected Cells: Blockade of Mitochondrial Cytochrome c Release and Caspase Activation. J Exp Med 187:487–496CrossRefPubMed
52.
Rajalingam K, Al Younes H, Muller A, Meyer TF, Szczepek AJ, Rudel T (2001) Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect Immun 69:7880–7888CrossRefPubMed
53.
Dean D, Powers VC (2001) Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Infect Immun 69:2442–2447CrossRefPubMed
54.
Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H (2002) The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol 14:444–451CrossRefPubMed
55.
Al-Younes HM, Rudel T, Brinkmann V, Szczepek AJ, Meyer TF (2001) Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell Microbiol 3:427–437CrossRefPubMed
56.
Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656CrossRefPubMed
57.
Coultas L, Bouillet P, Stanley EG, Brodnicki TC, Adams JM, Strasser A (2004) Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol 24:1570–1581CrossRefPubMed
58.
Xiao Y, Zhong Y, Greene W, Dong F, Zhong G (2004) Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect Immun 72:5470–5474CrossRefPubMed
59.
Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, Ying S, Hacker G (2004) Chlamydia Inhibit Host Cell Apoptosis by Degradation of Proapoptotic BH3-only Proteins. J Exp Med 200:905–916CrossRefPubMed
60.
Ying S, Seiffert BM, Hacker G, Fischer SF (2005) Broad degradation of BH3-only proteins during infection with Chlamydia trachomatis. Infect Immun (In press)
61.
McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96:625–634CrossRefPubMed
62.
Fischer SF, Harlander T, Vier J, Hacker G (2004) Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step. Infect Immun 72:1107–1115CrossRefPubMed
63.
Fields KA, Mead DJ, Dooley CA, Hackstadt T (2003) Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol Microbiol 48:671–683CrossRefPubMed
64.
Zhong G, Fan P, Ji H, Dong F, Huang Y (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193:935–942CrossRefPubMed
65.
Voges D, Zwickl P, Baumeister W (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015–1068CrossRefPubMed
66.
Hoyt MA, Coffino P (2004) Ubiquitin-free routes into the proteasome. Cell Mol Life Sci 61:1596–1600CrossRefPubMed
67.
Everett KD, Bush RM, Andersen AA (1999) Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 49(Pt 2):415–440PubMed
68.
Friedman MG, Dvoskin B, Kahane S (2003) Infections with the chlamydia-like microorganism Simkania negevensis, a possible emerging pathogen. Microbes Infect 5:1013–1021CrossRefPubMed
69.
Amann R, Springer N, Schonhuber W, Ludwig W, Schmid EN, Muller KD, Michel R (1997) Obligate intracellular bacterial parasites of acanthamoebae related to Chlamydia spp. Appl Environ Microbiol 63:115–121PubMed
70.
Horn M, Collingro A, Schmitz-Esser S, Beier CL, Purkhold U, Fartmann B, Brandt P, Nyakatura GJ, Droege M, Frishman D, Rattei T, Mewes HW, Wagner M (2004) Illuminating the evolutionary history of chlamydiae. Science 304:728–730CrossRefPubMed
71.
Ojcius DM, Souque P, Perfettini JL, Dautry-Varsat A (1998) Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci. J Immunol 161:4220–4226PubMed
72.
Perfettini JL, Reed JC, Israel N, Martinou JC, Dautry-Varsat A, Ojcius DM (2002) Role of Bcl-2 family members in caspase-independent apoptosis during Chlamydia infection. Infect Immun 70:55–61CrossRefPubMed
73.
Fischer SF, Schwarz C, Vier J, Hacker G (2001) Characterization of Antiapoptotic Activities of Chlamydia pneumoniae in Human Cells. Infect Immun 69:7121–7129CrossRefPubMed
Metadata
Title
Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus
Authors
Georg Häcker
Susanne Kirschnek
Silke F. Fischer
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 1/2006
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-005-0239-4

Other articles of this Issue 1/2006

Medical Microbiology and Immunology 1/2006 Go to the issue

Original Investigation

Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity

Original Investigation

A recombinant enolase from Anisakis simplex is differentially recognized in natural human and mouse experimental infections

Original Investigation

The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia

Original Investigation

Identification of RNA-binding regions on the P and V proteins of human parainfluenza virus type 2
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits